BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2928644)

  • 1. Production of toxic shock syndrome toxin 1 in a mouse model of Staphylococcus aureus abscess formation.
    Lee JC; Perez NE; Hopkins CA
    Rev Infect Dis; 1989; 11 Suppl 1():S254-9. PubMed ID: 2928644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
    Rosten PM; Bartlett KH; Chow AW
    J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.
    Valle J; Vadillo S; Piriz S; Gomez-Lucia E
    Appl Environ Microbiol; 1991 Mar; 57(3):889-91. PubMed ID: 2039240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of toxic shock syndrome toxin-1 production among Staphylococcus aureus strains and clinical implications.
    Naidu AS; Kamme C; Ljungh A; Wadström T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):337-44. PubMed ID: 2648709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
    Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
    BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of toxic shock syndrome toxin-1 (TSST-1) associated with Staphylococcus aureus from a pyogenic skin infection.
    Naidu AS; Rathna K; Naidu S; Rao PN; Rajyalakshmi K
    Acta Microbiol Hung; 1988; 35(1):35-40. PubMed ID: 3394489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
    Asano K; Narita K; Hirose S; Nakane A
    Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified ELISA for the detection of toxic shock syndrome toxin (TSST-1) in staphylococcal isolates.
    Fey H; Pfister H; Boerlin P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):363-6. PubMed ID: 3376616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1 production in Jordanian population.
    Daghistani HI; Issa AA; Shehabi AA
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):95-8. PubMed ID: 10640602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.
    Igarashi H; Fujikawa H; Shingaki M; Bergdoll MS
    J Clin Microbiol; 1986 Mar; 23(3):509-12. PubMed ID: 3082921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of enterotoxins and TSST-1 secreted by Staphylococcus aureus isolated from ruminant mastitis. Comparison of ELISA and immunoblot.
    Orden JA; Goyache J; Hernández J; Doménech A; Suárez G; Gómez-Lucía E
    J Appl Bacteriol; 1992 Jun; 72(6):486-9. PubMed ID: 1644704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
    Kunstmann G; Schröder E; Hasbach H; Pulverer G
    Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in burned children.
    Childs C; Edwards Jones V; Dawson M; Davenport PJ
    Burns; 1999 Sep; 25(6):473-6. PubMed ID: 10498353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
    Jacobson JA; Kasworm E; Daly JA
    Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.